Bibliographic Details
| Title: |
Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling. |
| Authors: |
Taylor SJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Dagger SA, Thien CB, Wikstrom ME, Langdon WY |
| Source: |
Blood [Blood] 2012 Nov 08; Vol. 120 (19), pp. 4049-57. Date of Electronic Publication: 2012 Sep 18. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
